Samuel J Reich Sab Biotherapeutics, Inc. (SABS) insider trading activity

SABS Quotes by TradingView

Samuel J Reich is CEO & EXECUTIVE CHAIRMAN of SAB Biotherapeutics, Inc.. Currently has a direct ownership of 219,001 shares of SABS, which is worth approximately $678,903. The most recent transaction as insider was on Nov 29, 2023, when has been sold 11,000 shares (Common Stock) at a price of $0.89 per share, resulting in proceeds of $9,790. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 219K
0% 3M change
5.29% 12M change
Total Value Held $678,903

Samuel J Reich Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 29 2023
BUY
Open market or private purchase
$9,790 $0.89 p/Share
11,000 Added 4.78%
219,001 Common Stock
May 20 2022
BUY
Other acquisition or disposition
-
207,001 Added 49.88%
208,001 Common Stock
Oct 14 2021
BUY
Open market or private purchase
$10,110 $10.11 p/Share
1,000 Added 50.0%
1,000 Common Stock
SJR

Samuel J Reich

CEO & EXECUTIVE CHAIRMAN
Sioux Falls, SD

Track Institutional and Insider Activities on SABS

Follow SAB Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SABS shares.

Notify only if

Insider Trading

Get notified when an Sab Biotherapeutics, Inc. insider buys or sells SABS shares.

Notify only if

News

Receive news related to SAB Biotherapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SABS